Cannatrek is a vertically integrated Australian company specialising in the cultivation, manufacture and delivery of quality-compliant plant-based medicines

We believe everyone has the right to quality healthcare, regardless of circumstances. We are committed to making plant-based medicines affordable and accessible for all.

We are building and evolving the industry. We manage the entire lifecycle of plant-based therapies, from growth and processing to distribution and sales.


LEGALISATION: A NEW ERA IN AUSTRALIAN HEALTHCARE

The Australian government's 2016 decision to legalise medicinal cannabis marked a historic turning point, ending nearly a century of prohibition.

For the first time since the 1920s the lawful research, production and distribution of plant-based medicines was possible. Patients were provided with a legal avenue to access medicinal cannabis. This kickstarted the rapid evolution of Australia's fastest-growing biotech industry, heralding a new era for patients and suppliers.

THE BIRTH OF CANNATREK

Long before founding Cannatrek, health economist Tommy Huppert foresaw the transformative potential of plant-based healthcare. He saw plant-based medicine as a legitimate alternative for patients left unsatisfied by traditional treatments.

Tommy's entrepreneurial drive and his interest in plant-based healthcare led him to establish Cannatrek in 2016. He began building a team who got straight to work, securing federal and state licenses to cultivate products in 2018.